0.1482
price down icon3.39%   -0.0052
 
loading
前日終値:
$0.1534
開ける:
$0.142
24時間の取引高:
49.21M
Relative Volume:
22.65
時価総額:
$13.45M
収益:
-
当期純損益:
$-31.88M
株価収益率:
-0.1976
EPS:
-0.75
ネットキャッシュフロー:
$-25.20M
1週間 パフォーマンス:
+2.28%
1か月 パフォーマンス:
-13.84%
6か月 パフォーマンス:
-51.36%
1年 パフォーマンス:
-85.61%
1日の値動き範囲:
Value
$0.1285
$0.1521
1週間の範囲:
Value
$0.1285
$0.187
52週間の値動き範囲:
Value
$0.112
$1.74

In 8 Bio Inc Stock (INAB) Company Profile

Name
名前
In 8 Bio Inc
Name
セクター
Healthcare (1170)
Name
電話
(646) 600-6438
Name
住所
EMPIRE STATE BUILDING, NEW YORK
Name
職員
18
Name
Twitter
Name
次回の収益日
Name
最新のSEC提出書
Name
INAB's Discussions on Twitter

INAB を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
INAB
In 8 Bio Inc
0.1482 13.15M 0 -31.88M -25.20M -0.75
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.58 26.10B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
442.05 111.96B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.35 42.96M 0 0 0 0.00
Biotechnology icon
VRNA
Verona Pharma Plc Adr
81.20 6.39B 0 -153.72M -103.81M -2.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
490.28 63.52B 14.09B 4.50B 2.96B 39.28

In 8 Bio Inc Stock (INAB) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-03-18 開始されました Laidlaw Buy
2022-08-30 開始されました H.C. Wainwright Buy

In 8 Bio Inc (INAB) 最新ニュース

pulisher
May 29, 2025

Fierce Biotech Layoff Tracker 2025: Keros cuts 70 jobs; iTeos winds down - Fierce Biotech

May 29, 2025
pulisher
May 28, 2025

Analysts Set Cabaletta Bio, Inc. (NASDAQ:CABA) Price Target at $20.33 - MarketBeat

May 28, 2025
pulisher
May 27, 2025

Palisade Bio Reports Positive Phase 1a Results for - GlobeNewswire

May 27, 2025
pulisher
May 27, 2025

Global Immunoprecipitation Market Set to Grow at a CAGR of 6-8%: Key Drivers and Challenges by 2029 - PharmiWeb.com

May 27, 2025
pulisher
May 26, 2025

DNA Polymerase Market to Grow at 6–8% CAGR Driven by Genomics, PCR, and CRISPR Technologies by 2029 - PharmiWeb.com

May 26, 2025
pulisher
May 22, 2025

Layoff Tracker: Boundless Laying Off 33% of Staff - BioSpace

May 22, 2025
pulisher
May 20, 2025

Caisse Française de Financement Local: EMTN 2025-8 SOCIAL - The Manila Times

May 20, 2025
pulisher
May 18, 2025

Dimensional Fund Advisors LP Sells 592,968 Shares of bluebird bio, Inc. (NASDAQ:BLUE) - Defense World

May 18, 2025
pulisher
May 14, 2025

KALA BIO: Q1 Earnings Snapshot - The Washington Post

May 14, 2025
pulisher
May 14, 2025

KALA BIO Reports First Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewswire

May 14, 2025
pulisher
May 14, 2025

Raymond James Financial Inc. Takes Position in 8×8, Inc. (NASDAQ:EGHT) - Defense World

May 14, 2025
pulisher
May 13, 2025

Why INmune Bio Inc (INMB) Is Skyrocketing So Far In 2025 - MSN

May 13, 2025
pulisher
May 13, 2025

INmune Bio, Inc. (NASDAQ:INMB) Q1 2025 Earnings Call Transcript - Insider Monkey

May 13, 2025
pulisher
May 12, 2025

Tevogen Bio's Business Model Addresses Biopharma Industry Challenges with Cost-Efficient Innovation - GlobeNewswire

May 12, 2025
pulisher
May 11, 2025

TELA Bio, Inc. (NASDAQ:TELA) Q1 2025 Earnings Call Transcript - Insider Monkey

May 11, 2025
pulisher
May 09, 2025

8 Best Medical Simulators On Steam, Ranked - Game Rant

May 09, 2025
pulisher
May 09, 2025

Nuvation Bio Inc. (NUVB): Among Billionaire David Abrams’ Stock Picks with Huge Upside Potential - Yahoo Finance

May 09, 2025
pulisher
May 08, 2025

bluebird bio, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before May 28, 2024 to Discuss Your RightsBLUE - ACCESS Newswire

May 08, 2025
pulisher
May 08, 2025

Shareholders that lost money on bluebird bio, Inc. (BLUE) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire

May 08, 2025
pulisher
May 08, 2025

INmune Bio Inc. Announces First Quarter 2025 Results and Provides Business Update - Yahoo Finance

May 08, 2025
pulisher
May 08, 2025

TELA Bio Reports First Quarter 2025 Financial Results - Yahoo Finance

May 08, 2025
pulisher
May 08, 2025

GRI Bio’s Interim Biomarker Data Demonstrate Positive Trend Towards Anti-Fibrotic Effect of GRI-0621 in First Twelve Patients of Ongoing Phase 2a Study in Idiopathic Pulmonary Fibrosis (“IPF”) - Yahoo Finance

May 08, 2025
pulisher
May 07, 2025

IN8bio Reports First Quarter 2025 Financial Results and Recent Business Highlights - GlobeNewswire Inc.

May 07, 2025
pulisher
May 07, 2025

TELA Bio Inc (TELA) Q1 2025 Earnings Report Preview: What to Expect - Yahoo Finance

May 07, 2025
pulisher
May 07, 2025

GRI Bio Continues to Drive Enrollment in Ongoing Phase 2a Study of GRI-0621 in Idiopathic Pulmonary Fibrosis (“IPF”) - Yahoo Finance

May 07, 2025
pulisher
May 06, 2025

TELA Bio Inc expected to post a loss of 20 cents a shareEarnings Preview - TradingView

May 06, 2025
pulisher
May 06, 2025

Instil Bio Inc expected to post a loss of $2.59 a shareEarnings Preview - TradingView

May 06, 2025
pulisher
May 06, 2025

Palisade Bio Presents Positive Preclinical Data Highlighting Potential of PALI-2108 as a Promising Colon-Specific PDE4 Inhibitor for the Treatment of Ulcerative Colitis and Other Inflammatory Bowel Diseases - GlobeNewswire

May 06, 2025
pulisher
May 05, 2025

INmune Bio Inc. to Report First Quarter 2025 Financial Results and Provide Corporate Update on Thursday, May 8th - The Manila Times

May 05, 2025
pulisher
May 01, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

May 01, 2025
pulisher
May 01, 2025

Nuvation Bio CFO to Share Latest Oncology Strategy at Exclusive Citizens Conference Next Week - Stock Titan

May 01, 2025
pulisher
May 01, 2025

Palisade Bio’s AI-Driven Approach to IBD Heterogeneity and - GlobeNewswire

May 01, 2025
pulisher
Apr 30, 2025

Adicet Bio to Participate in a Fireside Chat at the Citizens JMP Life Sciences Conference - BioSpace

Apr 30, 2025
pulisher
Apr 29, 2025

Annovis Bio Appoints Hui Liu as Director of Biostatistics - GlobeNewswire

Apr 29, 2025
pulisher
Apr 29, 2025

Belite Bio Announces Poster Presentations at the Association for Research in Vision and Ophthalmology 2025 Annual Meeting - Yahoo Finance

Apr 29, 2025
pulisher
Apr 27, 2025

Cerity Partners LLC Makes New Investment in Nuvation Bio Inc. (NYSE:NUVB) - Defense World

Apr 27, 2025
pulisher
Apr 25, 2025

Tevogen Bio Announces 2025 Annual Meeting - GlobeNewswire

Apr 25, 2025
pulisher
Apr 20, 2025

TELA Bio to Announce Q1 2025 Earnings on May 8 - MSN

Apr 20, 2025
pulisher
Apr 18, 2025

TELA Bio to Announce First Quarter 2025 Financial Results - The Manila Times

Apr 18, 2025
pulisher
Apr 17, 2025

Tevogen Bio Signs Agreement with CD 8 Technology - TipRanks

Apr 17, 2025
pulisher
Apr 17, 2025

Medical Tech Leader TELA Bio Schedules Q1 2025 Earnings: Key Growth Updates Expected - Stock Titan

Apr 17, 2025
pulisher
Apr 16, 2025

Is Gossamer Bio Inc. (NASDAQ:GOSS) the Best Penny Stock to Invest in Under $1? - Insider Monkey

Apr 16, 2025
pulisher
Apr 16, 2025

GRI Bio Announces Abstract Selected for Poster Discussion Session at the 2025 American Thoracic Society (ATS) International Conference - Yahoo Finance

Apr 16, 2025
pulisher
Apr 15, 2025

Vyant Bio (OTCMKTS:VYNT) Trading 7.8% Higher – Time to Buy? - Defense World

Apr 15, 2025
pulisher
Apr 10, 2025

Amtech Systems, Tesla And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Benzinga

Apr 10, 2025
pulisher
Apr 09, 2025

Palisade Bio Completes Dosing in Phase 1a Portion of Ongoing Phase 1a/b Study of PALI-2108 - GlobeNewswire

Apr 09, 2025
pulisher
Apr 09, 2025

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)April 8, 2025 - BioSpace

Apr 09, 2025
pulisher
Apr 08, 2025

South Korean firms ABL Bio, Yuhan advance bispecific antibodies in cancer treatment - Chosunbiz

Apr 08, 2025

In 8 Bio Inc (INAB) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$1.08
price up icon 1.89%
$30.14
price down icon 3.74%
$573.26
price down icon 1.32%
$304.56
price up icon 3.98%
$4.50
price down icon 3.02%
$490.28
price down icon 19.01%
大文字化:     |  ボリューム (24 時間):